Guardant Health (GH) Liabilities and Shareholders Equity (2017 - 2026)

Guardant Health has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $1.9 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1.9 billion, up 42.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 billion (up 9.37% YoY), and the FY2025 annual result was $2.0 billion, up 35.54% from the prior year.
• Liabilities and Shareholders Equity came in at $1.9 billion for Q1 2026 at Guardant Health, down from $2.0 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.1 billion in Q1 2022 to a low of $1.3 billion in Q3 2025.
• The 5-year median for Liabilities and Shareholders Equity is $1.7 billion (2022), against an average of $1.7 billion.
• Across the five-year window, Liabilities and Shareholders Equity slipped 29.02% in 2023 and soared 42.48% in 2026, its largest moves.
• Guardant Health's Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then rose by 10.96% to $1.8 billion in 2023, then retreated by 16.84% to $1.5 billion in 2024, then jumped by 35.54% to $2.0 billion in 2025, then decreased by 4.89% to $1.9 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.9 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.